Top compounds associated with response to GPI


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K44224150 CTRPv2 pan-cancer AAC 0.045 0.6
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC -0.022 0.6
mRNA canertinib CTRPv2 pan-cancer AAC -0.021 0.6
mRNA BRD-K97651142 CTRPv2 pan-cancer AAC 0.021 0.6
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.021 0.6
mRNA BRD8958 CTRPv2 pan-cancer AAC -0.022 0.6
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.02 0.6
mRNA pandacostat CTRPv2 pan-cancer AAC -0.021 0.6
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.018 0.6
mRNA BRD-K19103580 CTRPv2 pan-cancer AAC -0.021 0.6
Download CSV